Characteristics, Treatment Options for Patients With Advanced Gynecologic Cancers
A presentation at the 2023 ONA Summit reviewed diagnosis and treatment recommendations for uterine, ovarian, and endometrial cancers.
A presentation at the 2023 ONA Summit reviewed diagnosis and treatment recommendations for uterine, ovarian, and endometrial cancers.
Larger proportion of women with private or Medicare insurance receive diagnosis of early-stage cervical cancer.
Cervical cancer incidence has declined in recent years but have been increasing for ADC subtype at varying rates in racial and ethnic groups of women.
Compared with women aged <65 years, those aged ≥65 have lower late-stage five-year relative survival.
Only 81 of 1,318 patients had persistent disease at three months after treatment; 60 later achieved local control with no further treatment.
Researchers sought to determine whether survivors of gynecologic cancers had a higher risk of sexual dysfunction, compared with cancer-free women, and the risk factors for sexual dysfunction.
Vast majority of cancers diagnosed due to symptoms or other medical care.
Different patterns of age-specific incidence observed between countries with and without well-developed population-based screening and treatment.
Lower screening rates for cervical, breast, and colorectal cancers suggest ‘pattern of forgone care,’ according to researchers.
Sexual function less likely to be assessed in women versus men undergoing brachytherapy for genitourinary cancers.